Equity Overview
Price & Market Data
Price: $112.5
Daily Change: +$19.30 / 17.16%
Range: $98.68 - $120.9
Market Cap: $3,119,270,656
Volume: 4,543,904
Performance Metrics
1 Week: 23.92%
1 Month: 47.86%
3 Months: 53.58%
6 Months: 34.34%
1 Year: -12.40%
YTD: 78.83%
Company Details
Employees: 728
Sector: Health technology
Industry: Medical specialties
Country: United States
Details
TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its OCS includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for preservation of DBD donor hearts deemed unsuitable due to limitations of cold storage and for ex vivo reanimation, functional monitoring, and beating-heart preservation of donation-after-circulatory-death hearts; and OCS Liver for the preservation of DBD and DCD of donor livers. The company also developed national OCS program, a turnkey solution for outsourced organ retrieval; and provides OCS organ management and logistics services, including aviation and ground transportation, and other coordination activity. The company was founded in 1998 and is headquartered in Andover, Massachusetts.